Zuellig Pharma
Concise Prescribing Info
Fluvoxamine maleate
Depressive illness, symptoms of depressive disorder & obsessive compulsive disorder (OCD).
Dosage/Direction for Use
Depression Initially 50 or 100 mg daily as single dose in the evening, increase dose gradually until usual effective dose: 100 mg daily is reached. Prevention of depression recurrence 100 mg daily as single dose. OCD Adult Initially 50 mg daily for 3-4 days, increase dose gradually until usual effective dose: 100-300 mg daily is reached. Max: 300 mg daily. Adolescent & childn from 8 yr Initially 25 mg daily preferably at bedtime, may be increased in 25-mg increments every 4-7 days until usual effective dose: 50-200 mg daily is reached. Max: 200 mg daily.
May be taken with or without food: Swallow whole, do not chew.
Hypersenstivity. Combination w/ tizanidine & MAOIs. Concomitant use w/ pimozide & ramelteon.
Special Precautions
Discontinue use if seizures occur or increased seizure frequency; serotonin syndrome or NMS-like events develop. Avoid use in patients w/ unstable epilepsy. Monitor clinical worsening, suicidal behaviour or thoughts & unusual behaviour changes; patients w/ controlled epilepsy. History of suicide-related events & exhibiting significant degree of suicidal ideation; convulsive disorders; bleeding disorders & predisposing conditions eg, thrombocytopenia or coagulation disorders; DM, disturbed glycaemic control; mania/hypomania; akathisia/psychomotor restlessness; raised IOP or at risk of acute narrow-angle glaucoma. May cause sexual dysfunction symptoms. Not to be co-administered w/ terfenadine, astemizole, cisapride. Concomitant use w/ SSRIs, drugs affecting platelet function eg, atypical antipsychotics & phenothiazines, most TCAs, ASA, NSAIDs; drugs that increased risk of bleeding; electroconvulsive therapy. Long-term use. Avoid abrupt w/drawal. May affect ability to drive & use machines. Hepatic or renal insufficiency. May impair male fertility. Not to be used in women of childbearing potential, during pregnancy & lactation. Not to be used in childn & adolescents <18 yr w/ depression. Elderly.
Adverse Reactions
Anorexia; agitation, nervousness, anxiety, insomnia, somnolence, tremor, headache, dizziness; palpitations/tachycardia; abdominal pain, constipation, diarrhoea, dry mouth, dyspepsia, nausea, vomiting; hyperhidrosis; asthenia, malaise.
Drug Interactions
Risk of serotonin syndrome w/ MAOIs. Increased AUC & Cmax of ramelteon. Increased plasma levels of TCAs (eg, clomipramine, imipramine, amitriptyline), neuroleptics (eg, clozapine, olanzapine, quetiapine), benzodiazepines (eg, triazolam, midazolam, alprazolam, diazepam), caffeine, ropinirol, propranolol. Increased plasma conc & prolonged prothrombin time of warfarin. Cardiac toxicity w/ thioridazine. Enhanced serotonergic effects w/ other serotonergic agents eg, triptans, tramadol, SSRIs, St. John's wort prep; lithium. Increased risk of haemorrhage w/ oral anticoagulants. Avoid use w/ alcohol. Drugs w/ narrow therapeutic index; terfenadine, astemizole, cisapride, sildenafil.
MIMS Class
ATC Classification
N06AB08 - fluvoxamine ; Belongs to the class of selective serotonin reuptake inhibitors. Used in the management of depression.
Luvox FC tab 100 mg
Luvox FC tab 50 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in